Detalles de la búsqueda
1.
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma.
Blood
; 140(5): 491-503, 2022 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35476848
2.
Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma.
Blood
; 137(19): 2621-2633, 2021 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33512407
3.
Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma.
Blood Cancer Discov
; 5(2): 106-113, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38194367
4.
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia.
Mol Ther Oncolytics
; 31: 100751, 2023 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38075241
5.
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality.
Clin Cancer Res
; 29(6): 1114-1124, 2023 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36622700
6.
Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study.
Cardiooncology
; 9(1): 18, 2023 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37005652
7.
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion.
Sci Adv
; 9(38): eadg3919, 2023 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37738350
8.
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy.
Nat Med
; 29(4): 906-916, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36914893
9.
CD3 engagement as a new strategy for allogeneic "off-the-shelf" T cell therapy.
Mol Ther Oncolytics
; 24: 887-896, 2022 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35317526
10.
Outcomes of CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Patients with Reduced Renal Function Including Dialysis.
Transplant Cell Ther
; 28(12): 829.e1-829.e8, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36174934
11.
4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells.
J Immunother Cancer
; 9(10)2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34706886
12.
Incidence and Management of Effusions Before and After CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Large B Cell Lymphoma.
Transplant Cell Ther
; 27(3): 242.e1-242.e6, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33781520
13.
Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel.
Clin Cancer Res
; 26(18): 4823-4831, 2020 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32669372
14.
Transverse myelitis after anti-CD19 directed CAR T cell therapy for relapsed large B cell lymphoma.
EJHaem
; 3(1): 223-227, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35846190
Resultados
1 -
14
de 14
1
Próxima >
>>